Angiotensin-(1-7) receptor Mas antagonist (A779) influenced gliosis and reduced synaptic density in the spinal cord after peripheral axotomy

Peptides. 2020 Jul:129:170329. doi: 10.1016/j.peptides.2020.170329. Epub 2020 May 11.

Abstract

The peptide angiotensin-(1-7) [Ang (1-7)] and its receptor Mas are involved in controlling arterial pressure and display actions on the nervous system. In a previous study, our laboratory showed that A779 [(peptidyl antagonist of the Ang-(1-7)] treatment had a negative effect following a lesion of the sciatic nerve, possibly by delaying the responses of Schwann cells, resulting in a decreased axonal organization along with a slowed functional return. In the present work, we investigated the central cellular changes after sciatic nerve injury in rodents treated with A779 after two weeks. In the lumbar spinal cords, where the neuronal bodies that make up the sciatic are, the treatment with A779 showed reduced reactivity of astrocytes (p = 0.004, Mann-Whitney U test) and less synaptic density (p = 0.004, Mann-Whitney U test) after injury. Also, the treatment upregulated microglia activity in both sides (p = 0.004, Mann-Whitney U test), ipsilateral and contralateral to the lesion, of the spinal cord. In addition, the Mas expression in spine neurons was increased in response to axotomy especially after two weeks (p = 0.03, Mann-Whitney U test) following the nerve lesion in comparison to earlier stages after injury. Therefore, we can conclude that Ang-(1-7)/Mas axis plays a role during spinal cord recovery after peripheral nerve injury.

Keywords: Angiotensin (1-7); Astrocyte; Mas receptor; Microglia; Synapse.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin I / agonists*
  • Angiotensin II / analogs & derivatives*
  • Angiotensin II / therapeutic use
  • Animals
  • Astrocytes / drug effects
  • Axotomy*
  • Fluorescent Antibody Technique
  • Gliosis / drug therapy*
  • Gliosis / pathology*
  • Male
  • Mice, Inbred C57BL
  • Microglia / drug effects
  • Peptide Fragments / agonists*
  • Peptide Fragments / therapeutic use*
  • Receptors, G-Protein-Coupled / agonists*
  • Spinal Cord / drug effects
  • Synapses / drug effects*

Substances

  • 7-Ala-angiotensin (1-7)
  • Peptide Fragments
  • Receptors, G-Protein-Coupled
  • Angiotensin II
  • Angiotensin I
  • angiotensin I (1-7)